文献速递乳房整形与再造美容整形

跨性别女性雌激素刺激乳房反应分类BREST量表评估

The Breast Response to Estrogenic Stimulation in Transwomen Classification: Evaluation of Breast Response to Estrogenic Stimulation in Transwomen.
PubMed 文献 · Ann Plast Surg · 2021-01-01

多数患者为II型(25%)或IV型(37%),量表中度评分者间信度(κ=0.58),胸骨切迹至乳头距离和乳头至乳房下皱襞距离与量表相关,乳头至下皱襞距离及胸围与胸下围差值是BREST类型最强预测因子(OR分别为2.57和1.96)。

要点

  • BREST量表可分类跨性别女性激素治疗后乳房表型,多数为II型或IV型。
  • 乳头至乳房下皱襞距离及胸围与胸下围差值是BREST类型的独立预测因子。
  • 量表中度信度(κ=0.58),但与客观乳房测量指标相关,可用于多学科沟通。

核心结论

  • BREST量表能独特捕捉跨性别女性对激素治疗反应的乳房表型差异。
  • 量表中度评分者间信度,但与客观乳房测量相关,提供跨性别女性专用评估指标。

研究设计与样本

  • 使用新型BREST量表进行分类,比较不同BREST类型的术前人口学、解剖测量、手术技术和术后结果。

主要发现

  • 多数患者为BREST II型(25%)或IV型(37%)。
  • 3名整形外科医生间评分者间信度κ=0.58,为中度。
  • 胸骨切迹至乳头距离和乳头至乳房下皱襞距离与BREST量表相关。
  • 多因素逻辑回归显示乳头至乳房下皱襞距离(OR=2.57)和胸围与胸下围差值(OR=1.96)是BREST类型最强预测因子。
  • 控制混杂变量后,体重指数不是BREST类型的预测因子。

关键数值与推荐

  • BREST量表评分者间信度κ=0.58。
  • 乳头至乳房下皱襞距离预测BREST类型的OR=2.57。
  • 胸围与胸下围差值预测BREST类型的OR=1.96。

临床怎么用

  • BREST量表可为跨性别女性乳房发育评估提供共同语言,促进提供者、不同专科和保险公司间的沟通。
  • 临床可结合乳头至乳房下皱襞距离和胸围与胸下围差值等客观测量辅助BREST分型。

局限性

  • 量表存在一定主观性,评分者间信度仅为中度(κ=0.58)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hormone therapy with exogenous estrogen and/or spironolactone is commonly used in transfemales to induce breast development. However, inherent differences in adult male and female anatomy create persistent deformities and inadequate gender congruency despite glandular breast development. This includes nipple characteristics, position of inframammary fold, and the distribution of breast tissue. Accordingly, the Tanner stages do not accurately reflect these persistent deformities because they relate to breast development in transwomen. Herein, we describe a classification system for breast development in transwomen treated with hormone therapy. METHODS: Ninety-nine transfemale patients who underwent breast augmentation from 2014 to 2018 were retrospectively reviewed and categorized using a novel scheme, the Breast Response to Estrogenic Stimulation in Transwomen (BREST) scale. Preoperative demographics, anatomic measurements, surgical technique, and postoperative results were also compared among BREST types. RESULTS: Most patients were rated as BREST type II (25%) or type IV (37%). The BREST scale exhibited moderate interrater reliability (κ = 0.58) between 3 plastic surgeons. Objective breast measurements such as sternal notch-to-nipple distance and nipple-to-inframammary fold distance correlated with the BREST scale. Multivariate logistical regression identified the nipple-to-inframammary fold distance and different between the bust and chest circumference as the strongest predictors of BREST type (odds ratio, 2.57 and 1.96, respectively). Body mass index was not a predictor of BREST type after controlling for confound variables on multivariate analysis. CONCLUSIONS: The BREST scale uniquely captures the differences in breast phenotypes in transgender women according to hormone therapy response. Although some subjectivity exists with moderate interrater reliability, the BREST scale correlates with objective breast measurements. The BREST scale provides a transwoman-specific metric allowing for a common language in assessment of transgender breast development and optimal communication among providers, different specialties, and insurance companies.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Alcon A, Wang E, Oliver-Allen H, et al. The Breast Response to Estrogenic Stimulation in Transwomen Classification: Evaluation of Breast Response to Estrogenic Stimulation in Transwomen. Ann Plast Surg. 2021. PMID: 33559998. doi:10.1097/SAP.0000000000002729

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。